PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark. per.johansson@regionh.dk.\', \'Department of Intensive Care, Nordsjællands Hospital, Hillerød, Denmark.\', \'Department of Intensive Care, Herlev Hospital, Herlev, Denmark.\', \'Department of Intensive Care, Hvidovre Hospital, Hvidovre, Denmark.\', \'Department of Anaesthesiology, Rigshospitalet, Copenhagen, Denmark.\', \'Department of Intensive Care, Bispebjerg Hospital, Copenhagen, Denmark.\', \'Department of Intensive Care 4131, Rigshospitalet, Copenhagen, Denmark.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-04696-2
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 32847626
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
?:title
  • The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng/kg/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all